Free Trial

Trading of Rapt Therapeutics was halted at 09:39 AM EST due to "LULD pause".

Rapt Therapeutics (RAPT) News Today

Rapt Therapeutics logo
$10.61 +1.89 (+21.67%)
Closing price 04:00 PM Eastern
Extended Trading
$10.52 -0.09 (-0.90%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RAPT Latest News

HC Wainwright Forecasts Lower Earnings for Rapt Therapeutics
Rapt Therapeutics (NASDAQ:RAPT) Price Target Raised to $27.00
RAPT Therapeutics Inc.
RAPT Therapeutics Inc Ordinary Shares - Morningstar
Rapt Therapeutics appoints Jessica Savage as VP, clinical development
Get Rapt Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RAPT and its competitors with MarketBeat's FREE daily newsletter.

RAPT Media Mentions By Week

RAPT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RAPT
News Sentiment

0.81

0.99

Average
Medical
News Sentiment

RAPT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RAPT Articles
This Week

11

2

RAPT Articles
Average Week

Get Rapt Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RAPT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RAPT) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners